Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Diabetes and pregnancy; gestational diabetes
  • Published Date:
    5/26/2010
Filetype[PDF-1.24 MB]


Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Within-trial cost-effectiveness of lifestyle intervention using a 3-tier shared care approach for pregnancy outcomes in Chinese women with gestational diabetes
    Personal Author:
    Li, Weiqin; Zhang, Cuiping; Leng, Junhong; Shao, Ping; Tian, Huiguang; Zhang, Fuxia; Dong, Ling; Yu, Zhijie; Chan, Juliana C. N.; Hu, Gang; Zhang, Ping; Yang, Xilin;
    Published Date:
    August 20 2020
    Source:
    PLoS One. 2020; 15(8)
    Description:
    This study assessed within-trial cost-effectiveness of a shared care program (SC, n = 339) for pregnancy outcomes compared to usual care (UC, n = 361), as implemented in a randomized trial of Chinese women with gestational diabetes (GDM). SC consiste...
    File Type:
    Filetype[PDF - 445.38 KB]
  2. Vital Signs: Prescription Opioid Pain Reliever Use During Pregnancy — 34 U.S. Jurisdictions, 2019
    Personal Author:
    Ko, Jean Y.; D’Angelo, Denise V.; Haight, Sarah C.; Morrow, Brian; Cox, Shanna; Salvesen von Essen, Beatriz; Strahan, Andrea E.; Harrison, Leslie; Tevendale, Heather D.; Warner, Lee; Kroelinger, Charlan D.; Barfield, Wanda D.;
    Published Date:
    July 17 2020
    Source:
    MMWR Morb Mortal Wkly Rep. 69(28):897-903
    Description:
    Prescription opioid use during pregnancy has been associated with poor outcomes for mothers and infants. Studies using administrative data have estimated that 14%-22% of women filled a prescription for opioids during pregnancy; however, data on self-...
    File Type:
    Filetype[PDF - 335.25 KB]
  3. A National public health agenda for osteoarthritis : 2020 update
    Corporate Authors:
    Osteoarthritis Action Alliance.. Centers for Disease Control and Prevention (U.S.). Artritis Foundation..
    Published Date:
    4/30/20
    Description:
    Recognizing the high prevalence of OA and its rising health impact and economic consequences, the Centers for Disease Control and Prevention (CDC) and the Arthritis Foundation (AF) collaborated with other partners on A National Public Health Agenda f...
    File Type:
    Filetype[PDF - 3.00 MB]
  4. Assessing Pregnancy, Gestational Complications, and Co-morbidities in Women With Congenital Heart Defects (Data from ICD-9-CM Codes in 3 US Surveillance Sites)
    Personal Author:
    Raskind-Hood, Cheryl; Saraf, Anita; Riehle-Colarusso, Tiffany; Glidewell, Jill; Gurvitz, Michelle; Dunn, Julie E.; Lui, George K.; Van Zutphen, Alissa; McGarry, Claire; Hogue, Carol J.; Hoffman, Trenton; Rodriguez, Fred H.; Book, Wendy M.;
    Published Date:
    December 09 2019
    Source:
    Am J Cardiol. 125(5):812-819
    Description:
    Improved treatment of congenital heart defects (CHDs) has resulted in women with CHDs living to childbearing age. However, no US population-based systems exist to estimate pregnancy frequency or complications among women with CHDs. Cases were identif...
    File Type:
    Filetype[PDF - 452.49 KB]
  5. Periconceptional folic acid and risk for neural tube defects among higher risk pregnancies
    Personal Author:
    Petersen, Julie M.; Parker, Samantha E.; Benedum, Corey M.; Mitchell, Allen A.; Tinker, Sarah C.; Werler, Martha M.;
    Published Date:
    August 21 2019
    Source:
    Birth Defects Res. 111(19):1501-1512
    Description:
    BackgroundWomen with a previous neural tube defect (NTD)-affected pregnancy are recommended to consume 4,000 μg daily folic acid (FA) for prevention (10 times the general-population recommendation). Protection from doses between 400 and 4,000 μg fo...
    File Type:
    Filetype[PDF - 135.21 KB]